Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) insider Sukumar Nagendran sold 26,918 shares of Taysha Gene Therapies stock in a transaction that occurred on Monday, January 26th. Sukumar Nagendran also recently made the following trade(s):Get Taysha Gene Therapies alerts:On Friday, January 23rd, Sukumar Nagendran sold 89,132 shares of Taysha Gene Therapies stock. Institutional Investors Weigh In On Taysha Gene TherapiesTaysha Gene Therapies ( NASDAQ:TSHA Get Free Report ) last posted its quarterly earnings data on Tuesday, November 4th. View Our Latest Research Report on Taysha Gene TherapiesAbout Taysha Gene Therapies(Get Free Report)Taysha Gene Therapies, Inc (NASDAQ: TSHA) is a clinical-stage biotechnology company focused on developing gene therapies for rare monogenic diseases of the central nervous system. Featured StoriesReceive News & Ratings for Taysha Gene Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taysha Gene Therapies and related companies with MarketBeat.com's FREE daily email newsletter.